yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34554492-28CCC0EC-9C7D-48B1-8B60-61BB6DB6F4EA
Q34554492-28CCC0EC-9C7D-48B1-8B60-61BB6DB6F4EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34554492-28CCC0EC-9C7D-48B1-8B60-61BB6DB6F4EA
Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.
P2860
Q34554492-28CCC0EC-9C7D-48B1-8B60-61BB6DB6F4EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34554492-28CCC0EC-9C7D-48B1-8B60-61BB6DB6F4EA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5439300f452fc0b5fe7e12119e7a3ee9933d5f5c
P2860
Application of evidence from randomised controlled trials to general practice.